Akintunde (Tunde) Bello, MSc, PhD
Visionary · DISC type DsAkintunde (Tunde) Bello is a biopharmaceutical executive with over 25 years of experience in drug development across companies like Bristol Myers Squibb, Pfizer, and Sanofi. He currently serves as a Principal Consultant at Metrum Research Group, holds a board seat at Xilio Therapeutics, and earned his PhD from Kings College London.
He is dedicated to mentorship and leadership within the biopharmaceutical field, serving on the board of the RCDII Charity and receiving recognition from the Aleto Foundation for his efforts. Colleagues describe him as a passionate scientist who is a major positive influence on their careers.
He has contributed to the development, approval, and lifecycle management of 15 different marketed drugs across multiple therapeutic areas.
Read the full overview →How Akintunde shows up
They are very professional in their approach and can weigh multiple perspectives together. They exhibit a rare combination of being result-oriented but patient at the same time. Reading between the lines and seeing beyond your words comes naturally to them.
Topics Akintunde cares about
Work history
Media appearances
DISC profile (public)
Dominance (D)
Dominance (D) reflects how goal and task oriented a person is, and their ability to accomplish results irrespective of how demanding the circumstances might be. Those scoring high tend to be motivated by winning, competition, and success.
Other Metrum Research Group Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.